Pellecchia, Maurizio

Identification of a new JNK inhibitor targeting the JNK-JIP interaction site

Stebbins, J. L., De, S. K., Machleidt, T., Becattini, B., Vazquez, J., Kuntzen, C., Chen, L.-H., Cellitti, J. F., Riel-Mehan, M., Emdadi, A., et al. (2008) · Proceedings of the National Academy of Sciences

Protein Kinase Regulation and GTPase SignalingProtein Tyrosine Phosphatases

Cited by 186

Novel Targeted System To Deliver Chemotherapeutic Drugs to EphA2-Expressing Cancer Cells

Wang, S., Placzek, W. J., Stebbins, J. L., Mitra, S., Noberini, R., Koolpe, M., Zhang, Z., Dahl, R., Pasquale, E. B., & Pellecchia, M. (2012) · Journal of Medicinal Chemistry

Nanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery

Cited by 94

Ironing out cell death mechanisms

Reed, J. C., & Pellecchia, M. (2012) · Cell

Ferroptosis and cancer prognosisCell death mechanisms and regulation

Cited by 87

Inhibition of Siah2 ubiquitin ligase by vitamin K3 (menadione) attenuates hypoxia and MAPK signaling and blocks melanoma tumorigenesis

Shah, M., Stebbins, J. L., Dewing, A., Qi, J., Pellecchia, M., & Ronai, Z. A. (2009) · Pigment Cell & Melanoma Research

Ubiquitin and proteasome pathwaysMelanoma and MAPK Pathways

Cited by 85

Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide–Drug Conjugate

Salem, A. F., Wang, S., Billet, S., Chen, J.-F., Udompholkul, P., Gambini, L., Baggio, C., Tseng, H.-R., Posadas, E. M., Bhowmick, N. A., et al. (2018) · Journal of Medicinal Chemistry

Nanoparticle-Based Drug DeliveryChemical Synthesis and Analysis

Cited by 68

Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine

Quinn, B. A., Wang, S., Barile, E., Das, S. K., Emdad, L., Sarkar, D., De, S. K., Morvaridi, S. K., Stebbins, J. L., Pandol, S. J., et al. (2016) · Oncotarget

Pancreatic and Hepatic Oncology ResearchNanoparticle-Based Drug Delivery

Cited by 39